Low Risk vs High Risk MDS - What's the Difference?
Vložit
- čas přidán 19. 07. 2022
- In this webinar, Dr. Marlise Luskin from Dana Farber Cancer Institute will define high-risk MDS versus low-risk MDS, impact for patients and what treatment options are available.
This webinar is brought to you by the generous support of Celgene, Takeda and Jazz Pharmaceuticals.
Learning is hope is a great thing to remember. Thank you for this presentation. It has been the most helpful, recent information I have received since my husband was diagnosed in 2016. He is not eligible for transplant because he is on dialysis.
Please remember we are here for you. Email help@aamds.org, and there are webinars for caregivers as well, like this one: www.aamds.org/webinar/emotional-and-health-impact-caregiving-2021-winter-patient-family-conference. Please let us know if you'd like to talk with someone who has experienced what you are going through as well - help@aamds.org
Was diagnosed at 58 yrs old and am now 60. Hem/Onc is following blood counts which are dropping slowly. I have no idea what to expect in the future. I would never do a BMT but will this get me eventually? How long do I have in general? What is long term outlook? Thanks for the informative presentation.
Thank you for sharing this information. I just got diagnosed. I'm 64 years old and I have stage 4 lung cancer and ms. I hope 🙏🏼 I can beat this! This is my 5th time fighting cancer. I am trying to learn as much as I can to fight.
I read that the bone marrow transplant could heal MDS and stop the progression of MS. Do you agree with these findings? Thank you for your time and services. ❤️🙏🏼✝️
You may also find this recording useful about transplantation for older patients: www.aamds.org/webinar/transplant-older-patients-mds